Wednesday, January 11, 2017

Thoughts About 2017- Leaning More Toward Preservation of Capital/ 2016 Performance Numbers

1. Thoughts About 2017: I am not someone who experiences the phenomenon known generally as "animal spirits". Left Brain does not allow for that. TrumpEuphoria will pass as the real world starts to throw cold water on the economic nirvana now predicted by the thundering herd. 

I am far more positive on the U.S. economy in 2017 than on the U.S. stock market, as I recently outlined in this post:  Update For Portfolio Positioning And Management 2016 4th Quarter - South Gent | Seeking Alpha

I will make a bold prediction for 2017. The iShares 7-10 Year Treasury Bond ETF (IEF) and SPDR® S&P 500 ETF (SPY) will both have positive returns in the first quarter and negative real total returns for the year. 

Bonds: 

I increased my exchange traded bond and preferred stock basket by over $40K late last year based on an opinion that prices had fallen too far, too fast. I have already started the process of harvesting some profits, primarily in the Canadian reset equity preferred stocks that I started to buy last February. 

The ten year treasury started a parabolic increase in yield during mid-summer last year, rising from 1.37% (7/5/16) to 2.6% (12/15/16). Daily Treasury Yield Curve Rates That move resulted in 10% to 20% declines in several long duration exchange traded bonds and potentially perpetual fixed coupon equity preferred stocks which caused me to start a minor allocation shift into those securities as trades. I announced that allocation shift in my Comment blogs at SeekingAlpha and discussed the purchases there as well. (e.g. see my comments at South Gent's Comment Blog # 6: REITs, Preferred Stocks And Bonds, Regional Banks, Healthcare & Biotechs, CEFs, Currencies And International Trading - South Gent | Seeking Alpha)

It is important IMO for fixed income investors to recognize that the bond bull market started in 1982 and interest rates are at extremely low levels now throughout the developed world. This long term secular bull market has either already ended or will soon end. The last long term secular bond bear market lasted 32 years starting just prior to my birth.   

It is also important to recognize the many inflationary pressures that are building in the U.S. economy;  the overall increases in inflation expectations reflected in the pricing of 5 and 10 year TIPs; and the gradual removal of  extremely dovish FED monetary policies and a slow motion return to more normal policies. 








The breakeven inflation rate is the market's prediction of the average annual CPI rate.

Currently, a rise in U.S. intermediate and longer term rates is being restrained by the abnormal monetary policies of the ECB, BOJ and other European central banks that are keeping interest rates at lower levels.  Rates & Bonds - Bloomberg The ECB's benchmark rate is a negative .4% and QE is still in full swing. 

I am continuing my effort to control interest rate risk using the following strategies:     

1. Floating Rate Securities And Interest Rate Risks: I am buy floating rate securities when adding to fixed coupon ones. Those securities have the potential to increase their coupons during a rising rate period.
Most of the floater purchases have been Canadian reset equity preferred stocks. Some of those reset every quarter at spreads to the 3 month Canadian T Bill which is what I call a pure floater. Others reset every five years at a spread to the five year Canadian bond. For anyone unfamiliar with how the Canadian resets work, I have drag and dropped some recent discussions into the Appendix section below along with some links to prior posts.
I have also added some to my synthetic floater bond position. Those securities are complicated and probably need to be avoided by most investors. I have been buying and selling them since early 2009. They come in two basic flavors. The first are the pure floaters that pay a spread to a short term rate like the 3 month Treasury Bill or the 3 month Libor rate. The others pay the greater of a minimum coupon or a spread over short term rates. Those will require the Libor to increase significantly from current levels to trigger an increase in the coupon, whereas the coupons of the pure floaters will rise along with applicable short term rate.
2: Interest Rate Risk and Small Lot Trading: Another way that I cope with interest rate risk is to buy small lots, average down when prices decline further and potentially sell higher cost lots when and if there is another rally in bonds.
3. Interest Rate Risk and the Investment of All Cash Flow: I will also by using the entire cash flow generated by my bond and preferred stock positions to buy more of the same, provided interest rates continue to trend up. That will increase my yields and cash flow over a period where interest rates are rising in a persistent manner. I do not know now how high rates will go or whether we are only now at the start of a long term secular bear market in bonds.
4. Interest Rate Risk and Individual Bond Ladders: I can mitigate interest rate risk by buying individual bonds using a ladder approach. Most of those purchases will be part of my Short Term Bond/CD Ladder strategy, but I will extend maturities further out in time when and if I am adequately compensated for interest rate risk. 
My bond ladders will use individual TIPs, treasury bills and notes, and mostly high quality investment grade corporate bonds.
The treasury securities are bought either at auction or in the secondary market.
I can participate in treasury auctions directly through one of my brokers who do not charge a commission for those trades (e.g. Fidelity and Vanguard) or through my Treasury Direct account.
5. Interest Rate Risk and Bond ETFs: I am avoiding those bond funds where investors can withdraw funds (net outflows in ETFs and mutual funds) that cause the fund managers to sell securities into a declining market, thereby locking in lower prices and impairing the net asset value per share of the remaining shareholders. I call this form of interest rate risk "bond fund redemption risk". CEF bond funds do not face this particular form of interest rate risks but are exposed to other forms.
Stocks: I have argued for several years now that conditions were ripe for a long term secular bull market in stocks.  When I started to lay out my case to SeekingAlpha readers in late 2012 and early 2013, there were many who questioned my vision about the future (see e.g. my comments at Sorry Bulls, But This Is Still A Secular Bear Market-Seeking Alpha (2/25/13 Published Article); This Summer Slowdown Will Be Different Than The Previous 3 | Seeking AlphaThe Coming Decade Of Stocks, Part 2 -Seeking Alpha; Bret Jensen's article titled Stagflation: Coming Soon To A Market Near You | Seeking AlphaDow 14,000: Are You The Sucker? | Seeking AlphaBeware: A Large Bull Rides A Tiny Elephant | Seeking AlphaAnatomy Of A Market Bubble | Seeking Alpha)

Starting in early 2009 and prior to 2012, I leaned more toward a snap back rally in a long term secular bear market characterization similar to what happened after the 1974 meltdown, while also noting that the characterization did not make any difference for the first two years. The market would be going up regardless of the long term classification. 

The problem now is valuation and the lofty expectations  about the near future that are not likely IMO to happen. 




I would not be concerned with a 25.02 TTM GAAP P/E coming out of a recession. It is worrisome 7+ years into an economic recovery with no recession. The last recession ended in June 2009: nber.org/cycles The S & P 500 closed at 2,264 yesterday and at 676.53 on March 9, 2009. 

My general reaction to the current market's valuation is similar to past cycles where investors become too euphoric after an extended stock market rally.  It is easy to do when stock risk and recessions seem like ancient relics from the past. Long term stock bear markets, catastrophic stock market declines (defined as a relatively quick 45%+ decline), cyclical stock markets (20%+ declines), corrections (10% to 20% declines) and dips (5% to 10% declines) are regular dinner guests at stock market parties, particularly those thrown by right brain decision making. 

Those  euphoric stages always result in price multiples that are excessive for reasonably anticipated corporate profits. The excesses in valuation may last for several years (e.g. late 1960s and 1990s), but eventually the real world intervenes and throws rivers of cold water to drown the animal spirits.  

Sure, more borrowing and spending by the federal government on infrastructure will temporarily add jobs and some GDP growth in exchange for a continuation of the parabolic increases in federal debt that will ultimately be the unsustainable and will likely lead to another Great Depression after a series of failed treasury auctions. 

Tax cuts for corporations, and a lower repatriation tax, will increase corporate earnings but that will not easily translate into more job growth. Large corporations tend to increase their dividends, share buybacks and executive compensation packages with the savings. Jobs growth will be hard to come by with the nation near full employment now. 

The tax cuts envisioned by the Trump administration will not be for the bottom three quintiles who need extra money to meet daily expenses but will inure as in the past to those in the top quintile and particularly those in the top 1% who will generally refrain from spending the extra after tax income. 

The spending levels for the bottom four quintiles are impacted by other factors. A major boost in disposable income has resulted from the tsunami in mortgage refinancings at abnormally low long term rates. Wages are starting to increase at a faster rate than inflation as the job market becomes tighter and companies have to offer higher wages to non-skilled labor. Confidence about the future plays into consumer spending as well. Disposable income for the bottom 4 quintiles can be materially lifted by higher risk free interest rates given the size of household investments in savings accounts, money market accounts, CDs and treasury bills.  

Just look at this chart-Over $8.85 Trillion in Savings Accounts:




Risk free investments have produced negligible amounts of disposable income for over seven years now. Hopefully, that is starting to change and that will benefit an economy built on consumer spending.

However, it is certainly possible that federal assistance programs that add to disposable income for the bottom two quintiles, and particularly for the lowest, will be cut in the coming years. 

Over the past year, I have been paring my stock allocation and that is likely to continue for as long as the market continues its parabolic up move. I am not close yet to selling all stock positions which did occur in the late 1990s.    


For 2017, I will continue buying stocks as trades and will probably be a net buy of European equities as intermediate or longer term holds. 

While anyone who predicts the future needs to predict often, and maybe one of those predictions will prove prescient, my 2017 prediction is that the Vanguard FTSE Europe ETF  (VGK) will outperform the S & P 500, overcoming early weakness in the Euro, due to better stock valuations in European multinationals compared to their U.S. counterparts and higher prices for European financials, materials and energy sectors. 

2. 2016 Performance Numbers:

My 2016 performance numbers were adversely impacted by a cash allocation that was close to 40% earning almost nothing. The retirement accounts generally fluctuated between a 10% to 15% cash allocation, while two smaller taxable accounts had cash allocations exceeding 50%. 

The Schwab account, for example, has an average cash allocation of about 40% last year. Schwab calculated my 2016 account standard deviation ("SD") at 6.84 and the total return at 9.64%: 

                                       

That account will be managed to keep the SD within a 6 to 8 range. 

The SD is closest to a "moderate" portfolio balance defined by Schwab as weightings of 35% in the Barclay's U.S. Aggregate Bond Index, 35% in the S & P 500 index, 15% in the MSCI EAFE Index, 10% in the Russell 2000 and 5% in 3 month Treasury Bills. The 2016 SD for that mix was 6.79 with a 7.41% return. 

While my Schwab portfolio's SD was closest to that moderate benchmark, the portfolio did not resemble those weightings at all. The portfolio's main weighting at 40% was in cash earning less at Schwab than the 3 month T Bill last year.  

Some of the portfolios gain in risk assets resulted from short term trading. REITs, regional bank stocks, exchange traded bonds and preferred stocks contributed to the overall total return. A few commission free international ETFs were detractors from that 9.64% total return.  

My major change for 2017 will be to earn about 1.5% more than Schwab pays for idle cash and to continue an active trading strategy focusing on dividend paying stocks, exchange traded bonds and preferred stocks. The trading strategy will be cost effective through mid-summer due to an abundance of free trades. 

The Fidelity taxable account had a similar cash balance and a similar return of close to 10%. Fidelity has not yet calculated 2016 return numbers. 


Most of the funds used to purchase short term bonds and CDs have been sourced from the Fidelity Government MM fund, which paid almost nothing last year, so income in that account will increase this year over 2016. After draining cash out of that account early last year, and redirecting the funds to Interactive Brokers, I responded to a promotion for 500 free trades over a two year period by adding $100K in new funds, which brought my cash balance starting in August over 50%.  


The remaining positions in the Fidelity taxable account are mostly dividend paying blue chip stocks, a few remaining stock ETFs, several regional bank stock positions with large percentage gains, Canadian REITs, a greatly reduced number of CEFs, and a small number of exchange traded bonds (only 2  equity preferred stocks).  

The IB account, which generally fluctuated between 10% to 20% in cash earning nothing last year, had a time weighted return of 14.24%:


                             


IB does not calculate SD, but I would estimate that the SD is probably closer to the Moderately Aggressive risk category. There will be a lot of trading in that account, with the overall number of owned securities fluctuating between 75 to 125. 

A smaller satellite taxable accounts outperformed the IB account account with a high cash allocation due in large part to the robust year end rally in regional banks, stock selection in the REIT sector, and successful timing of trades (e.g. selling 100 OHI at over $37 bought at less than $30).  The satellite Vanguard taxable account was in line with the Schwab account with a greater cash allocation earning a higher yield. 


The Fidelity Roth IRA was up 27.9% last year. I will be lucky to hit 5% this year after a recent shift out of REITs and regional banks and into TIPs and short term high quality corporate bonds. 

The Vanguard IRA was up  13.7% with a bond centric portfolio. I have flushed out of that account all leveraged bond CEFs late last year and into early 2017 with the exception of GDO. The proceeds are being channelled mostly into short term treasuries and some minor buys of longer duration exchange traded bonds. The cash level has gone up significantly. Vanguard allowed investors to keep the Vanguard Prime MM fund as a non-sweep account which provides a superior income yield compared to other MM funds (e.g. Fidelity Government MM Fund or Fidelity Treasury MM fund, the two options available to individual investors at that firm). 


Compare Vanguard - Vanguard Prime Money Market Fund with the Fidelity ® Government Money Market Fund or the Schwab Bank Sweep (.03% last month) or IB (zero).  


My T.Rowe Price stock mutual funds slightly outperformed in the aggregate my Vanguard stock funds. Both mutual fund accounts have balanced fund exposure. 


The T. Rowe Price mutual fund account was slightly better at a 8.07% total return with close to a 15% cash allocation. That accounts tilts toward a slightly aggressive risk taking category. Last year was hurt by exposure to international funds, weighted close to 20%, including the T. Rowe Price New Asia fund which was up .6%. A conservative balanced fund has the heaviest weighting at close to 20% and that is the T. Rowe Price Capital Appreciation fund. That fund had a 8.22% total return last year:


T. Rowe Price Capital Appreciation Fund (PRWCX) Fund Performance and Returns


The second largest weighting is in the Dividend Growth fund where there are investments going back into the early 1990s but no new money purchases other than dividend reinvestments in over a decade: 

T. Rowe Price Dividend Growth Fund (PRDGX) Fund Performance and Returns

One of the better performing stock funds, which was originally bought in the early 1990s, was the Small Cap Stock fund (OTCFX) at a 18.57% total return:


T. Rowe Price Small-Cap Stock Fund (OTCFX) Fund Performance and Returns


I also own the T. Rowe Price financial sector fund which had a 16.91% total return last year: 

T. Rowe Price Financial Services Fund (PRISX) Fund Performance and Returns

For the Price mutual funds, I prohibit all selling. My only options are to turn on or off reinvestment and to buy using available cash. The reinvestment option has been turned off and I did receive significant year end cash distributions. So far, I have only reinvested $250 of that cash when I added to the Health Science fund (PRHSX) last Friday. Like the Vanguard health care sector fund, PRHSX had a down year:


T. Rowe Price Health Sciences Fund (PRHSX) Fund Performance and Returns




I view PRHSX as riskier than the Vanguard health sector fund due to its larger biotech concentration including a number of clinical stage companies. It also has the potential to soar higher:
2011 11.01%
2012 31.93%
2013 51.4%
2014 31.94%
2015 12.98
2016 (10.35%)

The 3 year SD is 17.01 which is way outside of my comfort zone. The 3 year SD for IEF is 5.47 and 10.72 for the S &  P 500 ETF SPY. That SD is okay in small doses for the OG. 
At the moment, I am more likely to buy that fund than any of the others.

The largest weighting in the Vanguard mutual fund account is their Equity Income fund: 

Vanguard Equity-Income Fund Admiral Shares (VEIRX) Fund Performance and Returns

Other positions are as follows: 

Vanguard Health Care Fund Investor Shares (VGHCX) Fund Performance and Returns

Vanguard Capital Opportunity Fund Investor Shares (VHCOX) Fund Performance and Returns

Vanguard Wellington™ Fund Investor Shares (VWELX) Fund Performance and Returns

Vanguard Star Fund Investor Shares (VGSTX) Fund Performance and Returns


The overall strategy will continue to be to match the S & P 500 total return numbers over a rolling five year period with a balanced portfolio generating substantially more income and a large cash allocation. Stocks, Bonds & Politics: Portfolio Management Goals-Snapshots of Performance Numbers YTD, 3 and 5 Years Cumulative 


That will be an easy bogey to hit for me when the S & P 500 market is up less than 10% or down any amount. I am giving up some return in years like 2013 in exchange for going down substantially less than years like 2008.


Tuesday, January 10, 2017

Short Term $1K Par Value Bond/CD Ladder: 1/10/17 Purchases /Current Exchange Traded Bond and Preferred Stock Basket

In addition to the two CNQ bonds maturing next January, and discussed in my last post, I added the following: 

ROTH IRA Short Term Bond/CD Purchases 

Bond Buys ($1 per bond Commission) 

All of these bonds are senior unsecured investment grade bonds and were bought in 1 bond lots under par value.  However, the $1 commission took me a smidgen over par value for the WFC bond. 


The Virginia Electric Power senior unsecured bond, referenced in the snapshot above, has been bought earlier in a taxable account. That purchase was discussed briefly in the comment section here: Short Term Bond Ladder - South Gent | Seeking Alpha or Update For Portfolio Positioning And Management 2016 4th Quarter - South Gent | Seeking Alpha.

I will keep my exposure to the securities issued by one company to less than $15K as a risk mitigation measure. That limit includes securities throughout the capital structure starting with common stock and ending with first lien bonds. I will exclude FDIC insured CDs from that limit but those investments are spread among a number of banks in relatively small amounts. 

My exposure to Vodafone is currently slightly less than $2K in senior unsecured debt. 

I am more likely to hit that limit with Dominion Resources (D) or Wells Fargo (WFC) securities, though I am not currently close.    


Virginia Electric Power (now called Dominion Resources): Matures 1/15/18

FINRA Page: Bond Detail (prospectus linked at the FINRA Page)

YTM at Total Cost = 1.509%

Bond Ratings:  

Moody's RatingA2 (02/01/2016)
Standard & Poor's RatingBBB+ (02/01/2016)
Fitch RatingA (02/01/2016)


Vodafone Group: Matures 9/26/17

FINRA Page:  Bond Detail (prospectus linked at FINRA Page)

YTM at Total Cost = 1.281%

Bond Ratings: 

Moody's RatingBaa1 (07/23/2014)
Standard & Poor's Rating
Fitch RatingBBB+ (08/26/2016)

Wells Fargo: Matures 1/16/18 

FINRA Page Bond Detail (prospectus linked at FINRA Page)

Bond Ratings: 

Moody's RatingA2 (05/14/2015)
Standard & Poor's RatingA (12/02/2015)
Fitch RatingAA- (10/04/2016)

YTM at Total Cost = 1.437%

ROTH IRA: FDIC Insured CD Buy (commission free at Fidelity)


$2K Wells Fargo Bank 1.55% CD Maturing 1/22/19 Monthly Interest Payments 

Taxable Account Short Term Bond/CD Purchases: 

Bond (2) Senior Unsecured BBT


FINRA Page: Bond Detail (prospectus linked at FINRA page)

Bond Ratings: 

Moody's RatingA2 (08/18/2015)
Standard & Poor's RatingA- (11/14/2012)
Fitch RatingA+ (10/04/2016)

YTM at Total Cost: 1.39%

I also own BBT common and have pared my position down to 171+ shares: 



Some of those shares were acquired in exchange for National Penn shares.  The last common share purchase was discussed here: 

3. Added 50 BBT at $32.35-Satellite Taxable


FDIC Insured CD Purchase (commission free at Fidelity) 

$2K J P Morgan 1.8% Maturing 1/20/20 Monthly Interest Payments

This short term bond/CD basket extends out to three years; so the JPM CD purchase was slightly outside of that time range. 

I am now close to the $200K allocated to this basket strategy. For an investor who generally moves at a snails pace, I have taken this allocation from zero in about 2 weeks which is abnormally fast for the Old Geezer.   

+++++++++++

Exchange Traded Bond and Preferred Stock Basket Strategy

I have nipped at the exchange traded bond and preferred stock basket ($25 par values, either in CADs or USDs): 

Basket as of 1/10/17: (click to expand)



I include some ETFs in this basket, which I do not own, for comparison purposes. Currently, the only own bond ETFs are the Guggenheim BulletShares 2020 Investment Grade Corporate Bond ETF (BSCK) and iShares Floating Rate Bond ETF (FLOT)

The primary dispositions involved profit taking in the Canadian equity preferred reset sector with the most profitable disposition being 300 shares of ENBPRP:  

2017 ENBPRP 300 Shares  +C$1,814  (USDs= +$1.458.25)

For that sale, I immediately converted the CAD proceeds into USDs which cost me 1% of the principal amount. 




Fidelity's 1% currency conversion fee is built into the conversion price. I also had to pay a C$19 Fidelity commission. Those two fees consumed a meaningful amount of my profit before fees and commissions. I have fired Fidelity as my international broker. IB would charge $2 for that currency conversion back into USDs (possibly C$3 for a 300 shares trade/100 shares is C$1).   


The primary reason for that exchange is that I have ceased buying Canadian securities in that Fidelity account. A secondary reason is that I do have concerns about how the CAD will react when and if Trump sets in motion the repeal of NAFTA, which he probably has the power to do as President without the approval of Congress. Yes, President Trump really could kill NAFTA - but it wouldn't be pretty - Nov. 15, 2016 He has certainly promised to do so during the campaign on numerous occasions unless Canada and Mexico meet his demands for revisions.  The market is currently assigning a zero chance of a trade war erupting with Mexico, Canada and/or China. 

About 75% of Canada's exports go to the U.S. Top Canadian officials met Trump team for trade talks: paper | Reuters

The flip side is that Canada imports more goods from the U.S. than it exports to the U.S. Foreign Trade-Census Bureau 

A lot of havoc can happen quickly in trade relations.    

I still own 200 ENBPRB held in my IB account. 

For the Canadian reset equity preferred stocks, I have a realized profit YTD of C$2,481 and have increased my CAD stash through those dispositions by C$9,758. I am using them in part as a hedge for longer duration fixed coupon bonds and potentially perpetual preferred stocks.  I classify the Canadian resets as part of my floating rate equity preferred category. Snapshots can be found in the Gateway Post for that topic: Stocks, Bonds & Politics: Advantages and Disadvantages of Equity Preferred Floating Rate Securities 

That classification excludes Synthetic Floaters which pay interest and are classified with other bonds in the Trust Certificate legal form of ownership. 

Short Term Bond/CD Ladder: Bought 2 Canadian Natural Resources 1.75% Senior Unsecured Bonds at 99.826 Maturing on 1/15/18

Earlier today, I went down further on the credit rating scales to buy 2 Canadian Resources 1.75% senior unsecured bonds. This bond is currently rated Baa3 by Moody's or just one notch above junk. 

Moody's downgraded CNQ's debt to Baa3 from Baa1 in January 2016: Moody's downgrades Canadian Natural Resources to Baa3; outlook negative

S & P has a BBB+ rating with a stable outlook and DBRS is currently at BBB with a negative outlook. Canadian Natural Resources - Credit Ratings


This senior unsecured bond was originally issued in 2014 and matures on 1/15/18.  


The FINRA trade page shows that my YTM is 1.825% based on my total cost and 1.926% before Fidelity's $2 commission: 


At the time of my purchase, the one year treasury yield was .8%, United States Rates & Bonds - Bloomberg

While I am taking on some credit risk for an additional 1% over the one year treasury yield, I am not currently concerned about CNQ's ability to pay off this bond next January. 

I also own CNQ's common stock which is near break-even based on the current $31.62 share price. 



The short term bond/CD will top out soon near $200K. The ladder is hyper-sensitive to a rise in short term interest rates with multiple securities maturing each month through 2018. This strategy is predicated on the belief that short term rates will gradually rise and will return to something resembling normal over the next few years. 

As securities mature throughout 2017, I am anticipating that the proceeds can be used to buy securities maturing in 2019 at higher rates than now. 

The ladder is also intended to generate at a minimum 1% more per annum than the Fidelity Government Money Market fund that is the primary funding source for this ladder. While I have not done a precise calculation, I am now at about a 1.5% spread over that low yielding MM fund. 

U.S. treasuries are included in the ladder along with high quality short term corporate bonds, mostly rated A- or higher and bought at discounts to par value. The yield-to-maturity ("YTM") for those bonds will generally be higher than the coupon rate. 

The shortest maturity instruments will be the 4 week treasury bills bought in my Treasury Direct account where I have scheduled 25 reinvestments which can be changed later. 

I am buying short term fixed coupon U.S. treasuries either at auction or in the secondary market which can be done commission free at Schwab, Fidelity and Vanguard. Some other brokers may charge a commission even for auction orders (e.g. TD Ameritrade).  

Except for the 4 week treasury bills, the purchased securities start to mature in March 2017. There are already multiple securities that mature throughout every month from March 2017 through December 2018. A few securities have been bought with 2019 maturities. The intent is to fill out the 2019 maturities with the proceeds received from securities maturing in 2017 and then to use the 2018 maturities to fill out the 18 month period starting on 1/1/20.  

Monday, January 9, 2017

GMTA: Sold 30 at $24.5-Used Commission Free Trade-Small Ball in Potentially Long Duration Exchange Trade Bonds

GATX Corp. 5.625% Senior Notes due 2066 (GMTA) 


GMTA is an Exchange Traded Senior Bond which is currently rated Baa2 by Moody's and BBB by S & P. 



This senior unsecured bond was sold to the public at $25 last May. The issuer has the right to redeem on or after 5/30/2021 "at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, on the principal amount of the notes being redeemed to the applicable redemption date." If not redeemed early at the issuer's option, the bond will mature on 5/30/2066.  

Prospectus 
Position in Schwab Account Prior to Pare: 






I sold the highest cost 30 share lot at $24.5 that was bought at $24.06 (11/29/16) and kept the 50 share lot bought at $22.23 (12/14) and a 20 share lot bought at $22.95 (12/12). 



Closed 1/9/16 at $$24.56
Yield at That Price = 5.73%
Last Quarterly Ex Interest Date: 11/10/16

All of those lots were bought with commission free trades and would not have been in that manner at Schwab's regular commission rate. 

By selling my highest cost lot, I reduced my average cost per share from $22.92 to $22.44, which mitigates future interest rate risk and increases my current yield as well. I will consider buying back that lot at less than $21.75 or up to 50 more shares at less than $20. The foregoing summarizes one trading strategy designed to mitigate interest rate risk. 


The lowest cost lot in that series of odd lot purchases was made in a ROTH IRA at $21.76 and is still owned.   



I now own 110 GMTA shares as part of my Exchange Traded Bonds and Preferred Stocks Basket Strategy. 

GATX SEC Filings 

2016 3rd Quarter Results 

GATX Analyst Estimates

I decided a few weeks ago to buy some longer duration bonds and to attempt interest rate risk management through a variety of measures summarized here:  Summary of Portfolio Management and Positioning at Update For Portfolio Positioning And Management 2016 4th Quarter - South Gent | Seeking Alpha

Short Term Bond Ladder: Bought 6 Month Treasury Bill At Auction and 2 Anheuser Busch Senior Unsecured Maturing on 1/17/18

I have been discussing this particular strategy here: Short Term Bond Ladder - South Gent | Seeking Alpha

I have decided to increase the size again.

Today, I participated in the 6 month treasury bill auction:



The interest is the difference between the auction price and par value.

In a Roth IRA account, I also bought account the Anheuser Busch 1.25% senior unsecured bond maturing on 1/17/18:


I later added one more in my IB account where the commission is $1 per bond.

I now own four of those bonds.

FIRNA PAGE: Bonds Detail

I now anticipate that the short term bond/CD ladder will top out near $200K.

Arantana Therapeutics (PETX) and Merrimack Pharmaceuticals (MACK)

The following are the last two comments that I published at SeekingAlpha:


PETX (own 100 shares-Lotto Ticket):
Aratana Therapeutics, Inc. (PETX)
$8.55 +0.77 (+9.90%)
As of 12:23 PM EST

I did not see any specific PETX news to account for today's move. The shares have been extremely volatile and were up 42% last year:
Why Aratana Therapeutics Inc. Rocketed 42.7% Higher in 2016 -- The Motley Fool
 

Sometimes, the stock spikes based on a knee jerk reaction to acquisition news news that does not involve a company and that may be the case today.
The privately held Mars company, which has a significant pet food business headquartered in Franklin Tennessee, has agreed to acquire VCA Inc.:
VCA Inc. (WOOF)
$90.64 +$19.87 (+28.07%)
As of 12:28 PM EST.

WOOF operates animal hospitals and provides laboratory and consulting for veterinarians.
There has been a lot of acquisition activity in the pet sector over the past few years:
Profit From Trends In The Pet Care Industry | Seeking Alpha
I view PETX as an acquisition candidate given its small market cap and the receipt of three FDA approvals last year
PETX is a drug company focused on animal health.
I first bought 50 shares and discussed that purchase here:
 
2. Bought 50 PETX at $6.43: Update For Healthcare Basket Strategy As Of 7/29/16-Growing Lottery Ticket Component - South Gent | Seeking Alpha
 

The stock has been on a roller coaster rise since that July 2016 purchase: Historical Prices

After one of its periodic dips, I bought another 50 shares at $7.34, an average up, and discussed that trade in Comment Blog # 5: at Seeking Alpha. 

PETX has drifted down some by mid-afternoon and last traded at $8.31, up 6.815 as of 1:58 E.S.T.   

+++++++

MACK: Notwithstanding the market's negative reaction to MACK's announcement's announcement today,  I went ahead and bought another 50 shares this morning at $3.85 using a commission free trade. The other lot is in the IB account. MACK is still well within the definition of a Lottery Ticket.

Merrimack Concludes Strategic Review; Announces Plan to Divest Assets and Sharpen Strategic Focus
Another way to look at this deal, which is not consistent with the current pricing, is that it does monetize ONIVIDE and removes the concern about dilutive share offerings to finance further ONIVIDE trials while retaining benefits in the milestone payments in the event other indications are approved for marketing. In the materials released so far, I did not see any MACK obligation to continue funding those trials in order to receive the milestone payments. Those materials include a slideshow: Merrimack Pharmaceuticals (MACK) Investor Presentation - Slideshow- Seeking Alpha

I also read parts of the acquisition agreement itself which states at page 2 that MACK is transferring "all rights to perform research with respect to, Develop (including clinical development), manufacture, sell, distribute, license, promote and use (or cause to be performed, Developed, manufactured, sold, distributed, licensed, promoted and used) the Transferred Products, including all rights and claims to all clinical study data, reports and analyses to the extent related to the Transferred Products". EX-2.1: SEC Filing

On a related issue, MACK will not have to raise additional capital to further its remaining pipeline drugs into the second half of 2019.
The first MACK dividend of $1.54 looks like close to a sure thing. That mitigates the risk some for a purchase now. Any further dividends, when and if received, would further de-risk stock ownership at the current price. If all milestone payments are made, then the cumulative value of all dividends would exceed the current price.
It is of course virtually impossible to say one way or the other whether the remaining pipeline products will succeed. I am without question unqualified to render an opinion on that subject.
MACK says that seribantumab is now its leading pipeline candidate (page 12 of slide show).
The "U.S. Food and Drug Administration (FDA) has granted seribantumab, also known as MM-121, Fast Track designation for development in patients with heregulin-positive, locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has progressed following immunotherapy." FDA Grants Merrimack Fast Track Designation for Seribantumab (MM-121) in Non-small Cell Lung Cancer 

And, MACK just had a pipeline failure as I have discussed previously. 

++++++

MACK Purchase Today: 50 at $3.85 (commission free at Schwab-over 400 free trades left)




I last sold 100 MACK at $6.43: 




I discussed buying 50 shares of that 100 share lot here: Item # 5 Bought 50 MACK at $5.35: Update For Healthcare Basket Strategy As Of 7/29/16-Growing Lottery Ticket Component - South Gent | Seeking Alpha  

I then bought back 50 shares at $3.6 last Friday in my IB account: 


  

There are several possible reasons for the poor response to MACK's announcement today: (1) Investors believe that ONIVDE was sold at too low of a price or the price for ONIVDE was low due to its disappointing launch which continued into the last quarter; (2) too much of the ONIVDE potential revenues for MACK are backloaded into new FDA indication approvals; (3) the market is not confident that those milestone payments will actually be received; (4) investors are disappointed that MACK decided to stay independent; (5) investors lack confidence in the remaining pipeline and/or (6) the remaining pipeline products are just too far away from securing marketing approval to place value on them.

I am now at 150 MACK shares as a Lotto Ticket. 

Coming Back to This Blog

Starting today, I will be posting only at this website. I will be discussing daily some of my trades, similar to what I have been doing recently at SeekingAlpha in my Comment Instablogs.   

I will no longer be posting or commenting at SeekingAlpha: 


I do not like the advertisements adorning my SeekingAlpha Instablog. My blogs have always been free of those advertisements, and there will be none here.  

I also find it irritating that Instablogs that are nothing more than advertisements for a subscription service have more readers.  I can now avoid that irritation by ignoring the Instablog rankings altogether, since I expect to fall out of the top 100 soon enough. 


I have turned on the comment feature, but I will have to approve any comments prior to publication. That is necessary to avoid an endless number of spam comments that will start to appear when there is no moderation. 

Saturday, August 27, 2016

Updates

I have quit providing links to updates published at SeekingAlpha.

I would suggest bookmarking this page:  South Gent's Instablogs | Seeking Alpha

As noted in a recent blog, I will be transitioning to publishing one blog per quarter:

Future Blogs Will Only Be On A Quarterly Basis - South Gent | Seeking Alpha

I will be leaving substantive comments to my most recent SA Instablog, including some references to portfolio changes.

The most recent Instablog is this one:   South Gent's Comment Blog # 8: REITs, Preferred Stocks And Bonds, Regional Banks, Healthcare & Biotechs, CEFs, Currencies And International Trading - South Gent | Seeking Alpha

This is a link to my last quarterly update: Update For Portfolio Positioning And Management 2016 4th Quarter - South Gent | Seeking Alpha

12/23/16  Short Term Bond Ladder - South Gent | Seeking Alpha

Tuesday, August 2, 2016

Friday, July 29, 2016

Update for Healthcare Basket Strategy as of 7-29-16-Growing Lottery Ticket Component

The easiest way to track what I am doing or saying is to become a follower at SeekingAlpha and to check the "track new comments" box at the end of each Instablog. 

I was somewhat taken back when I looked at the rankings for SA Instablog authors and noted several authors who are using the Instablog format to sell subscriptions.  Top Instablogs | Seeking Alpha (e.g. Superinvestor Bulletin's Instablogs | Seeking Alpha).  I receive zilch and I am not trying to sell myself or anything else.  

Several of these Instablog advertisements are scattered throughout the SA Instablog universe and provide no useful or meaningful information IMO. They are exactly what they appear to be: advertisements for a subscription service. 

Then there are those that could fill a Twitter message with a few more words. No one has ever accused me of such brevity.  Nothing informative about an investment can be put in a 140 word narrative but those Twitter Want-To-Be Instablogs are not likely to lose anyone's short, and growing shorter, attention span.  You Now Have a Shorter Attention Span Than a Goldfish | TIME And one of our presidential contenders will need to struggle mightily to achieve the attentions span of a goldfish.  




Update For Healthcare Basket Strategy As Of 7/29/16 - South Gent | Seeking Alpha

South Gent's Activity feed | Seeking Alpha

Thursday, July 28, 2016

Update for Equity REIT Basket Strategy as of 7/28/16

The easiest way to track what I am doing or saying is to become a follower at SeekingAlpha and to check the "track new comments" box at the end of each Instablog. 

I was somewhat taken back when I looked at the rankings for SA Instablog authors and noted several authors who are using the Instablog format to sell subscriptions.  Top Instablogs | Seeking Alpha (e.g. Superinvestor Bulletin's Instablogs | Seeking Alpha).  I receive zilch and I am not trying to sell myself or anything else.  

Several of these Instablog advertisements are scattered throughout the SA Instablog universe and provide no useful or meaningful information IMO. They are exactly what they appear to be: advertisements for a subscription service. 

Then there are those that could fill a Twitter message with a few more words. No one has ever accused me of such brevity.  Nothing informative about an investment can be put in a 140 word narrative but those Twitter Want-To-Be Instablogs are not likely to lose anyones short, and growing shorter, attention span.  I read several of them this evening for the first time


Link to 6856 SA Activities: South Gent's Activity feed | Seeking Alpha